Friday 6-20-2014 Amgen Inc (AMGN) $AMGN opened at 118.23

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-20-2014 Amgen Inc (AMGN) $AMGN opened at 118.23 hitting the high price of 121.00 and a day low of 117.83 with a total volume of 7,326,514. AMGN had a previous close of 117.85 and has been seeing an average volume of 2,571,800.

Overall Average: 64% Buy

Recent stock forum discussions about AMGN http://investorshangout.com/search?q=AMGN&...mp;yt0=Go!

Final Glance: Biotechnology companies
AP - Fri Jun 20, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading: (full story)

Midday Glance: Biotechnology companies
AP - Fri Jun 20, 12:26PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.: (full story)

Early Glance: Biotechnology companies
AP - Fri Jun 20, 9:35AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.: (full story)

Amgen Rises 1.14% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 18, 4:13PM CDT
Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $115.50 to a high of $117.56. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $116.91 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Look for Shares of Amgen to Potentially Pullback after Yesterday's 1.14% Rise
Comtex SmarTrend(R) - Wed Jun 18, 4:13PM CDT
Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $115.50 to a high of $117.56. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $116.91 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Vital Signs - Healthcare News - The Analyst's Perspective February 2014 Issue
M2 - Wed Jun 18, 6:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dj8ssn/vital_signs) has announced the addition of the "Vital Signs - Healthcare News - The Analyst's Perspective February 2014 Issue" report to their offering. This issue of Vital Signs, released on February 28, 2014, discusses three M&A transactions this month by Nestle, Myriad Genetics, and Fludigm' and what these deals mean for the industry. Additionally, Illumina's first stab at personalized medicine through a partnership with Amgen is explored. For more information visit http://www.researchandmarkets.com/research/dj...ital_signs About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. (full story)

3 Undervalued Amgen Growth Opportunities to Watch
Stephen D., Simpson,, The Motley Fool - Motley Fool - Mon Jun 16, 4:30PM CDT
Amgen hasn't put as many eggs into the megablockbuster basket as Merck or Bristol-Myers Squibb , nor has it sought to utterly dominate a therapeutic area the way Biogen Idec may dominate MS. What Amgen does offer, though, is a deep pipeline... (full story)

Amgen Joins The National Cancer Institute And Research Partners To Help Accelerate Development Of Personalized Treatment Approaches For Squamous Cell Lung Cancer
PR Newswire - Mon Jun 16, 3:03PM CDT
Amgen (NASDAQ:AMGN) announced today that it will collaborate with the National Cancer Institute (NCI), part of the National Institutes of Health, and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a groundbreaking new clinical trial program that will use biomarker-driven research and genomic profiling to match squamous cell lung cancer patients to investigational treatments based on their individual cancer profiles. Lung-MAP is the first trial of its kind to study a large number of rare lung cancer subsets under one trial protocol. (full story)

Groundbreaking Collaborative Clinical Trial Launched
PR Newswire - Mon Jun 16, 8:00AM CDT
A unique public-private collaboration among the National Cancer Institute (NCI), part of the National Institutes of Health, SWOG Cancer Research, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), five pharmaceutical companies (Amgen, Genentech, Pfizer, AstraZeneca, and AstraZeneca's global biologics R&D arm, MedImmune), and Foundation Medicine today announced the initiation of the Lung Cancer Master Protocol (Lung-MAP) trial. (full story)

Is Gene Therapy Medicine's Next Big Thing?
Todd Campbell, The Motley Fool - Motley Fool - Sat Jun 14, 12:05PM CDT
Bluebird Bio is a small company with big ideas. The clinical stage biotechnology company is researching novel treatments that seek to insert missing genes into patient stem cells. The science behind  Bluebird's approach is so compelling that ... (full story)

The Zacks Analyst Blog Highlights: China Mobile, China Petroleum and Chemical, Trina Solar, AstraZeneca and Amgen
PR Newswire - Fri Jun 13, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the China Mobile Limited (NYSE:CHL-Free Report), China Petroleum and Chemical Corp. (NYSE:SNP-Free Report), Trina Solar Limited (NYSE:TSL-Free Report), AstraZeneca (NYSE:AZN-Free Report) andAmgen (Nasdaq:AMGN-Free Report). (full story)

Amgen Inc. (AMGN) Stock Research Links

AMGN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Carbonization Furnaces Turn Waste Rules Into Demand

Updated Category News Views 84

Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 104

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Mindstream’s Jordan AI Campus Faces Its First Real Test

Updated Category News Views 31

Jordan’s AI ambitions just got attached to a very large gas meter. Mindstream Energy has unveiled a plan for an AI-ready data-center campus at Al-Risha in Mafraq Governorate, built around dedicated natural-gas generation rather than a conventional dependence on the utility grid. The headline number is 400 megawatts of eventual capacity. The number that matters first is...

Continue Reading
ACOLT Bets on Gold, Craft, and a Sci-Fi Story World

Updated Category News Views 74

A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...

Continue Reading
Receipts Turns Vegas Party Shirts Into AR Keepsakes

Updated Category News Views 123

A shirt that coughs up a Vegas weekend when scanned is either a smart little keepsake trick or a privacy headache wearing sequins. Receipts™, introduced by Las Vegas-based Naked City Couture and the AR Trading Card Company, is betting it can be the former. The concept is simple enough: friends wear the apparel, capture photos and videos during a trip, upload those...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 71

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 144

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading
Hyster-Yale’s $135 Million Convert Carries Real Cost

Updated Category News Views 143

Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....

Continue Reading
Tigerlily Takes Its Advocacy Model to Ovarian Cancer

Updated Category News Views 166

Ovarian cancer has a nasty habit of hiding behind symptoms people are taught to shrug off. Persistent bloating or pelvic pain can look like any number of ordinary problems, and that ambiguity is exactly why practical, trusted education matters. Tigerlily Foundation's new ovarian cancer initiative is not a flashy breakthrough claim. It is a grounded attempt to help women...

Continue Reading
Makera A1S Tests the Desktop CNC Metal-Cutting Promise

Updated Category News Views 61

Aluminum chips are where desktop-machine marketing stops bluffing, and Makera is leaning right into that test with the A1S. The company opened global pre-orders on November 18 for a machine aimed squarely at the awkward middle ground: users who have outgrown entry-level hobby gear but do not have room, budget, or patience for a full industrial setup. That is a real market...

Continue Reading

Top 5 Most Recently Viewed Articles

Future Growth of the Premium Chocolate Sector: Insights and Trends

Updated Category News Views 85

An Insight into the Premium Chocolate Market The global premium chocolate market is experiencing remarkable growth, with projections indicating an increase of USD 20.8 billion between 2024 and 2028. This growth is expected to occur at a compound annual growth rate (CAGR) of 9.48%. Key drivers for this rise encompass new product launches and evolving consumer preferences....

Continue Reading
Lovesac's Commitment to Sustainability: The 2024 ESG Report

Updated Category News Views 260

Understanding Lovesac's 2024 ESG Report The Lovesac Company (NASDAQ: LOVE) has recently published its Environmental, Social, and Governance (ESG) Report for the fiscal year ending February 4, 2024. This comprehensive report showcases the company’s unwavering commitment to sustainability and responsible business practices, emphasizing their innovative product offerings...

Continue Reading
How High-Net-Worth Investors Can Save Millions in Taxes

Updated Category News Views 171

Strategies for High-Net-Worth Investors to Manage Tax Implications In a world where technology and artificial intelligence are reshaping the investment landscape, the CEO of Wealthstone, Zak Gardezy, offers new insights for high-net-worth individuals. His recent publication, Secrets of a Wealth Advisor: How To Diversify Concentrated Stock Tax Efficiently, focuses on...

Continue Reading
Major Leadership Change at Camping World Holdings Inc. Revealed

Updated Category News Views 251

Marcus Lemonis Steps Down from Camping World Holdings Inc. Marcus Lemonis, a prominent entrepreneur and television personality famed for his roles in popular shows, has announced his departure as CEO of Camping World Holdings Inc. (NYSE: CWH). This announcement marks a significant change for the company Lemonis co-founded, which has grown into a leading name in the...

Continue Reading
Market Outlook Update: Novozymes' Stock Rating Downgrade

Updated Category News Views 131

Recent Downgrade of Novozymes Stock by Citi Novozymes A/S (OTC: NVZMY) recently faced a significant shift in its market perception as Citi has downgraded the company’s stock rating from Neutral to Sell. Even with this downgrade, the price target has seen a slight improvement—from DKK390.00 to DKK400.00. This change arrives despite the company showcasing a remarkable...

Continue Reading